SWS Medical Unveils Innovative Renal Solutions at ERA 2026 Conference in Glasgow

SWS Medical Unveils Innovative Renal Solutions at ERA 2026 Conference

From June 3 to 6, 2026, SWS Medical will make its anticipated debut at the ERA 2026 Conference in Glasgow. This event is an important gathering for nephrologists, industry leaders, and partners, showcasing the latest advancements in renal care and dialysis technology.

Located at Booth D-350, SWS Medical is excited to present its next-generation blood purification solutions that reflect its commitment to innovation in the field of nephrology. The company, which boasts integrated capabilities spanning research and development to global distribution, has established itself as a key player in dialysis and blood purification systems in intensive care settings.

Among the highlights of their presentation will be the new dialysis platforms, including the SWS-4000 and SWS-6000 series, which are among the leading dialysis systems in China. These systems are contributing significantly to the industry, capturing an estimated 20% market share in 2025. The SWS-6000 features unique certified monitoring of essential treatment parameters and the SWS-4000 is equipped with an online HDF system, both designed to ensure safer and more effective treatment through intelligent monitoring and automation.

Another centerpiece is the award-winning SWS-5000 machine, recognized as the top TRSC machine in China for three consecutive years. This all-in-one platform supports integrated multi-organ blood purification treatments across renal, hepatic, cardiac, pulmonary, and pancreatic applications.

SWS Medical's offerings also include advanced dialyzers made with exclusive steam sterilization technology and 100% BPA-free materials. This ensures high solute clearance and reliable ultrafiltration performance, alongside filters for dialysis fluid and hemoperfusion cartridges that enhance blood purification therapies.

Furthermore, the company's integrated management platform fosters connectivity among dialysis centers, practitioners, and patients through offerings like the Data Hub and Hemodialysis Management System. This innovation aids in transforming data into safer and smarter patient care delivery.

Based in Chongqing, China, SWS Medical is a publicly traded medical device manufacturer specializing in blood purification solutions for dialysis and intensive care. The company plays a leading role in defining the future of blood purification in China and is committed to advancing industry standards. As a key member of the Strategic Alliance for Technological Innovation in the Chinese Blood Purification Industry, SWS Medical contributes to the development of national and sector standards while complying with international quality and regulatory requirements, including CE marking and ISO 13485:2016 certification.

The era of innovation in renal care is here, and SWS Medical is poised to lead the charge alongside nephrologists and industry partners at ERA 2026. With its cutting-edge technology and commitment to healthcare excellence, the company is setting new standards for the future of dialysis and patient care.

To learn more, visit swsdialysis.com.